Literature DB >> 29033097

A systematic review of the inclusion of mechanisms of action in NIH-funded intervention trials to improve medication adherence.

Donald Edmondson1, Louise Falzon2, Kevin J Sundquist2, Jacob Julian2, Laura Meli3, Jennifer A Sumner2, Ian M Kronish2.   

Abstract

Medication nonadherence contributes to morbidity/mortality, but adherence interventions yield small and inconsistent effects. Understanding the mechanisms underlying initiation and maintenance of adherence could improve interventions. The National Institutes of Health (NIH) support adherence research, but it is unclear whether existing NIH-funded research incorporates mechanisms. We conducted a systematic review to determine the proportion of NIH-funded adherence trials that have tested hypothesized mechanisms of intervention effects. We included randomized and quasi-randomized NIH-funded trials with medication adherence in adults as the primary outcome. Studies were identified by searching electronic databases from inception to 6/2016, references, and clinicaltrials.gov. Two of 18 (11%) NIH-funded trials tested a hypothesized mechanism of an intervention's effect on medication adherence. Another 44 studies with medication adherence as a secondary outcome were described in protocol form, and are either ongoing or never published results, but none mentioned mechanism tests. Overall, 3% of NIH-funded trials with adherence as an outcome conducted, or plan to conduct, tests of behavior change mechanisms. These results mirror previous findings that very few studies of behavior change interventions actually test the mechanism by which the intervention is hypothesized to improve health behaviors. We must understand mechanisms if we are to improve the effectiveness of interventions.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Interventions; Mechanisms; Medication adherence

Mesh:

Year:  2017        PMID: 29033097      PMCID: PMC5800992          DOI: 10.1016/j.brat.2017.10.001

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  39 in total

1.  Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations.

Authors:  Thomas J Bramley; Philip P Gerbino; Brian S Nightengale; Feride Frech-Tamas
Journal:  J Manag Care Pharm       Date:  2006-04

2.  From ideas to efficacy: The ORBIT model for developing behavioral treatments for chronic diseases.

Authors:  Susan M Czajkowski; Lynda H Powell; Nancy Adler; Sylvie Naar-King; Kim D Reynolds; Christine M Hunter; Barbara Laraia; Deborah H Olster; Frank M Perna; Janey C Peterson; Elissa Epel; Josephine E Boyington; Mary E Charlson
Journal:  Health Psychol       Date:  2015-02-02       Impact factor: 4.267

Review 3.  Medication adherence: a call for action.

Authors:  Hayden B Bosworth; Bradi B Granger; Phil Mendys; Ralph Brindis; Rebecca Burkholder; Susan M Czajkowski; Jodi G Daniel; Inger Ekman; Michael Ho; Mimi Johnson; Stephen E Kimmel; Larry Z Liu; John Musaus; William H Shrank; Elizabeth Whalley Buono; Karen Weiss; Christopher B Granger
Journal:  Am Heart J       Date:  2011-09       Impact factor: 4.749

Review 4.  Interventions used to improve control of blood pressure in patients with hypertension.

Authors:  T Fahey; K Schroeder; S Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

5.  Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs.

Authors:  Alice Dragomir; Robert Côté; Louise Roy; Lucie Blais; Lyne Lalonde; Anick Bérard; Sylvie Perreault
Journal:  Med Care       Date:  2010-05       Impact factor: 2.983

6.  Posttraumatic stress disorder and adherence to medications in survivors of strokes and transient ischemic attacks.

Authors:  Ian M Kronish; Donald Edmondson; Judith Z Goldfinger; Kezhen Fei; Carol R Horowitz
Journal:  Stroke       Date:  2012-05-22       Impact factor: 7.914

7.  Impact of medication adherence on hospitalization risk and healthcare cost.

Authors:  Michael C Sokol; Kimberly A McGuigan; Robert R Verbrugge; Robert S Epstein
Journal:  Med Care       Date:  2005-06       Impact factor: 2.983

8.  Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.

Authors:  Sayed H Naderi; Jonathan P Bestwick; David S Wald
Journal:  Am J Med       Date:  2012-06-27       Impact factor: 4.965

Review 9.  A systematic literature review of psychosocial and behavioral factors associated with initial medication adherence: a report of the ISPOR medication adherence & persistence special interest group.

Authors:  John E Zeber; Elizabeth Manias; Allison F Williams; David Hutchins; Waka A Udezi; Craig S Roberts; Andrew M Peterson
Journal:  Value Health       Date:  2013-07-10       Impact factor: 5.725

Review 10.  Medication adherence: its importance in cardiovascular outcomes.

Authors:  P Michael Ho; Chris L Bryson; John S Rumsfeld
Journal:  Circulation       Date:  2009-06-16       Impact factor: 29.690

View more
  9 in total

1.  Effectiveness of interventions targeting self-regulation to improve adherence to chronic disease medications: a meta-review of meta-analyses.

Authors:  Tracey E Wilson; Emily A Hennessy; Louise Falzon; Rebekah Boyd; Ian M Kronish; Jeffrey L Birk
Journal:  Health Psychol Rev       Date:  2020-01-13

Review 2.  Psychological Distress After Sudden Cardiac Arrest and Its Impact on Recovery.

Authors:  Sachin Agarwal; Jeffrey L Birk; Sabine L Abukhadra; Danielle A Rojas; Talea M Cornelius; Maja Bergman; Bernard P Chang; Donald E Edmondson; Ian M Kronish
Journal:  Curr Cardiol Rep       Date:  2022-08-03       Impact factor: 3.955

3.  Intervening on fear after acute cardiac events: Rationale and design of the INFORM randomized clinical trial.

Authors:  Jeffrey L Birk; Robin Cumella; David Lopez-Veneros; Ammie Jurado; Emily K Romero; Amit Lazarov; Ian M Kronish
Journal:  Health Psychol       Date:  2020-09       Impact factor: 4.267

4.  Effectiveness and sustainability of a structured group-based educational program (MEDIHEALTH) in improving medication adherence among Malay patients with underlying type 2 diabetes mellitus in Sarawak State of Malaysia: study protocol of a randomized controlled trial.

Authors:  Chuo Yew Ting; Shahren Ahmad Zaidi Adruce; Mohamed Azmi Hassali; Hiram Ting; Chien Joo Lim; Rachel Sing-Kiat Ting; Abu Hassan Alshaari Abd Jabar; Nor Anizah Osman; Izzul Syazwan Shuib; Shing Chyi Loo; Sui Theng Sim; Su Ee Lim; Donald E Morisky
Journal:  Trials       Date:  2018-06-05       Impact factor: 2.279

5.  Enhancing the Impact of Implementation Strategies in Healthcare: A Research Agenda.

Authors:  Byron J Powell; Maria E Fernandez; Nathaniel J Williams; Gregory A Aarons; Rinad S Beidas; Cara C Lewis; Sheena M McHugh; Bryan J Weiner
Journal:  Front Public Health       Date:  2019-01-22

6.  A randomized controlled trial in schools aimed at exploring mechanisms of change of a multifaceted implementation strategy for promoting mental health at the workplace.

Authors:  Lydia Kwak; Anna Toropova; Byron J Powell; Rebecca Lengnick-Hall; Irene Jensen; Gunnar Bergström; Liselotte Schäfer Elinder; Kjerstin Stigmar; Charlotte Wåhlin; Christina Björklund
Journal:  Implement Sci       Date:  2022-09-01       Impact factor: 7.960

7.  The Role of Alcohol-Related Behavioral Risk in the Design of HIV Prevention Interventions in the Era of Antiretrovirals: Alcohol Challenge Studies and Research Agenda.

Authors:  William H George; Jessica A Blayney; Cynthia A Stappenbeck; Kelly Cue Davis
Journal:  AIDS Behav       Date:  2021-07-09

Review 8.  Mindfulness-based interventions for medication adherence: A systematic review and narrative synthesis.

Authors:  William R Nardi; Eric B Loucks; Stacey Springs; Don Operario; Ian M Kronish; Brandon A Gaudiano; Shufang Sun
Journal:  J Psychosom Res       Date:  2021-07-26       Impact factor: 4.620

9.  The Implementation Research Logic Model: a method for planning, executing, reporting, and synthesizing implementation projects.

Authors:  Justin D Smith; Dennis H Li; Miriam R Rafferty
Journal:  Implement Sci       Date:  2020-09-25       Impact factor: 7.327

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.